Cardiac Resynchronization Therapy in Cardiogenic Shock: A Case-Based Discussion

Cureus. 2021 Sep 21;13(9):e18157. doi: 10.7759/cureus.18157. eCollection 2021 Sep.

Abstract

Cardiac resynchronization therapy (CRT) has consistently proven its capability to improve the left ventricular ejection fraction (LVEF). The benefits and indications for this therapy have been elucidated in current heart failure guidelines. However, it remains a topic of discussion if there is a role for it in acute heart failure syndromes (AHFSs). We present the case of a 55-year-old male with a medical history of alcohol-induced cardiomyopathy presenting with a new left bundle branch block, a widened QRS (154 ms), and cardiogenic shock (CS). After a lack of improvement with optimal medical management, CRT was used as a last resort. After implantation, the patient had a satisfactory clinical course and the LVEF improved. At the four-month follow-up, he underwent an outpatient transthoracic echocardiogram with further augmentation of his LVEF, improvement of his functional class, and no reported acute heart failure events. This case illustrates a potential therapeutic option for CS with a widened QRS. Prospective trials should include AHFSs to clarify the utility of CRT in this patient population.

Keywords: cardiac electrophysiology; cardiac resynchronization therapy (crt); cardiogenic shock; cardiology; critical care; internal medicine; interventional cardiology; multiorgan failure.

Publication types

  • Case Reports